Carpal tunnel syndrome in diabetes mellitus
Curr Diabetes Rev. 2021 Aug 31. doi: 10.2174/1573399817666210901114610. Online ahead of print.ABSTRACTThe aim of the present brief review was to discuss carpal tunnel syndrome (CTS) in diabetes mellitus (DM). Generally, CTS is more common in DM, especially in subjects with coexisting diabetic polyneuropathy (DPN) and/or long DM duration. There is no agreement if it is more frequent in type 1 or type 2 DM. The precise underlying mechanisms are not entirely clear but appear to involve hyperglycaemia-induced median nerve oedema, increased sensitivity to exogenous trauma and nerve myelin ischaemia and axonal degeneration. More recently, increased vascular endothelial growth factor (VEGF) and advanced glycation endproducts (AGEs) appear to also play an important role. Median nerve conduction study remains the cornerstone of CTS diagnosis in DM, being more sensitive than clinical examination. Treatment of CTS is medical or surgical. The latter appears now to be equally effective in subjects with vs. without DM in terms of recurrence rates and quality of life.PMID:34468300 | DOI:10.2174/1573399817666210901114610
Source: Current Diabetes Reviews - Category: Endocrinology Authors: Nikolaos Papanas Stella Papachristou Iliana Stamatiou Source Type: research
More News: Carpal Tunnel Syndrome | Diabetes | Diabetes Mellitus | Diabetes Type 1 | Diabetes Type 2 | Endocrinology | Study